Sign inJoin waitlistJoin the waitlist

Benjamin Herzberg

Associate Director, Experimental Therapeutics/Phase I Program, HICCC · HICCC

Credentials: · · · · ·

History

CUMC
Present

Memorial Sloan-Kettering Cancer Center
Massachusetts General Hospital
Massachusetts General Hospital
Harvard Medical School and MIT Program in Health Sciences and Technology
2015
Memorial Sloan-Kettering Cancer Center
Princeton University

Research

Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Review · The Oncologist · 2017 · First of 3 authors · 127 citations
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve EGFR-Mutant Metastatic Non-Small Cell Lung Cancer…
Journal of Clinical Oncology · 2025 · 57 citations
Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases
Nature Medicine · 2025 · 55 citations

Catherine Shu
7 papers
Anjali Saqi
6 papers
Brian Henick
6 papers
LC
Lanyi Chen
4 papers · 4 as a fellow
AS
Alexander Spira
3 papers
Aparna Hegde
3 papers
Benjamin Izar
3 papers
GR
Gregory Riely
3 papers
KA
Kathryn Arbour
3 papers
Mahesh Mansukhani
3 papers
Nilofer Azad
3 papers
AS
Alexander Starodub
2 papers

Clinical trials

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2032
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Site PI · Recruiting · Phase 1
Nested Therapeutics, Inc
2024–2029